These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9819676)

  • 1. Phenotypic analysis of PBMCs from uterine cervix cancer patients with high natural killer activity.
    Pinel MI; Pires V; Harab RC; Rumjanek VM
    J Clin Lab Immunol; 1997; 49(2):83-9. PubMed ID: 9819676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells.
    Gerosa F; Tommasi M; Benati C; Gandini G; Libonati M; Tridente G; Carra G; Trinchieri G
    Cell Immunol; 1993 Sep; 150(2):382-90. PubMed ID: 8103709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.
    Liberati AM; De Angelis V; Fizzotti M; Schippa M; Cecchini M; Adiuto D; Di Clemente F; Palmisano L; Micozzi E; Zuccaccia M
    Cancer Immunol Immunother; 1994 May; 38(5):323-31. PubMed ID: 7512888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha.
    Kutza J; Murasko DM
    Cell Immunol; 1994 Apr; 155(1):195-204. PubMed ID: 7513259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
    Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
    Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotypic profiles of peripheral blood lymphocytes on the day of embryo transfer in women undergoing in vitro fertilization.
    Baczkowski T; Kurzawa R
    Folia Histochem Cytobiol; 2007; 45 Suppl 1():S73-7. PubMed ID: 18292839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanoma.
    Konjević G; Jović V; Vuletić A; Radulović S; Jelić S; Spuzić I
    Eur J Clin Invest; 2007 Nov; 37(11):887-96. PubMed ID: 17973783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
    Naume B; Gately M; Espevik T
    J Immunol; 1992 Apr; 148(8):2429-36. PubMed ID: 1373169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.
    Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Shehata H; Bansal AS
    Hum Reprod; 2004 Oct; 19(10):2395-400. PubMed ID: 15319390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of IL-7 and IL-2 on highly enriched CD56+ natural killer cells. A comparative study.
    Naume B; Espevik T
    J Immunol; 1991 Oct; 147(7):2208-14. PubMed ID: 1717551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon alpha induces expression of the CD69 activation antigen in human resting NK cells, while interferon gamma and tumor necrosis factor alpha are ineffective.
    Gerosa F; Scardoni M; Tommasi M; Benati C; Snelli L; Gandini G; Libonati M; Tridente G; Carra G
    Int J Cancer; 1991 May; 48(3):473-5. PubMed ID: 1904052
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
    McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
    Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.
    Caligiuri MA; Murray C; Robertson MJ; Wang E; Cochran K; Cameron C; Schow P; Ross ME; Klumpp TR; Soiffer RJ
    J Clin Invest; 1993 Jan; 91(1):123-32. PubMed ID: 7678599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma.
    Ohira M; Nishida S; Tryphonopoulos P; Tekin A; Selvaggi G; Moon J; Levi D; Ricordi C; Ishiyama K; Tanaka Y; Ohdan H; Tzakis AG
    Cell Transplant; 2012; 21(7):1397-406. PubMed ID: 22469170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower concentrations of methyl-β-cyclodextrin combined with interleukin-2 can preferentially induce activation and proliferation of natural killer cells in human peripheral blood.
    Lü HZ; Zhu AY; Chen Y; Tang J; Li BQ
    Hum Immunol; 2011 Jul; 72(7):538-46. PubMed ID: 21540068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12.
    Naume B; Johnsen AC; Espevik T; Sundan A
    Eur J Immunol; 1993 Aug; 23(8):1831-8. PubMed ID: 7688307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-major histocompatibility complex-restricted killer cells in human cord blood: generation and cytotoxic activity in recombinant interleukin-2-supplemented cultures.
    Malygin AM; Timonen T
    Immunology; 1993 Jul; 79(3):506-8. PubMed ID: 7691729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
    Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
    J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria.
    Van Tol EA; Verspaget HW; Peña AS; Kraemer CV; Lamers CB
    Eur J Immunol; 1992 Jan; 22(1):23-9. PubMed ID: 1370415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.